These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 27150874

  • 1. Postoperative Atypical Hemolytic Uremic Syndrome Treated Successfully with Eculizumab.
    Yasuda S, Yamamoto M, Fukuda T, Ohtsuka Y, Miura O.
    Intern Med; 2016; 55(9):1171-5. PubMed ID: 27150874
    [Abstract] [Full Text] [Related]

  • 2. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N, Ayer M, Ergen A, Ozturk S.
    Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
    [Abstract] [Full Text] [Related]

  • 3. [Atypical hemolytic uremic syndrome in an elderly patient successfully treated with eculizumab].
    Fukasawa C, Ooishi S, Kumagai T, Koshiisi M, Sueki Y, Nakajima K, Mitsumori T, Yoshida Y, Kato H, Nangaku M, Miyata T, Kirito K.
    Rinsho Ketsueki; 2018 Jun; 59(2):182-186. PubMed ID: 29515071
    [Abstract] [Full Text] [Related]

  • 4. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V, Gupta M, Elrifai M, Moftakhar B, Ensley MJ, Vachharajani TJ, Sethi SK, Raina R.
    Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of Eculizumab Therapy for Atypical Hemolytic Uremic Syndrome Recurrence and Antibody-Mediated Rejection Progress After Renal Transplantation With Preformed Donor-Specific Antibodies: Case Report.
    Yamamoto T, Watarai Y, Futamura K, Okada M, Tsujita M, Hiramitsu T, Goto N, Narumi S, Takeda A, Kobayashi T.
    Transplant Proc; 2017 Apr; 49(1):159-162. PubMed ID: 28104125
    [Abstract] [Full Text] [Related]

  • 6. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
    Barlas UK, Kıhtır HS, Goknar N, Ersoy M, Akcay N, Sevketoglu E.
    Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan.
    Ito N, Hataya H, Saida K, Amano Y, Hidaka Y, Motoyoshi Y, Ohta T, Yoshida Y, Terano C, Iwasa T, Kubota W, Takada H, Hara T, Fujimura Y, Ito S.
    Clin Exp Nephrol; 2016 Apr; 20(2):265-72. PubMed ID: 26156042
    [Abstract] [Full Text] [Related]

  • 8. [Use of Eculizumab in atypical hemolytic uremic syndrome after renal transplantation].
    Teixeira CI, Mota RG, Afonso BG, Carneiro TV, Meira GS, Mendonça DU.
    J Bras Nefrol; 2015 Apr; 37(1):127-30. PubMed ID: 25923760
    [Abstract] [Full Text] [Related]

  • 9. Renal recovery with eculizumab in atypical hemolytic uremic syndrome following prolonged dialysis.
    Povey H, Vundru R, Junglee N, Jibani M.
    Clin Nephrol; 2014 Nov; 82(5):326-31. PubMed ID: 23557793
    [Abstract] [Full Text] [Related]

  • 10. [Atypical hemolytic uremic syndrome with C3 p.I1157T missense mutation successfully treated with eculizumab].
    Okano M, Matsumoto T, Nakamori Y, Ino K, Miyazaki K, Fujieda A, Sugimoto Y, Tawara I, Yamaguchi M, Ohishi K, Miwa H, Masuya M, Wada H, Katayama N.
    Rinsho Ketsueki; 2018 Nov; 59(2):178-181. PubMed ID: 29515070
    [Abstract] [Full Text] [Related]

  • 11. ATYPICAL HEMOLYTIC UREMIC SYNDROME IN AN ADULT SUCCESSFULLY TREATED WITH ECULIZUMAB.
    Chaudoir C, Ong MG, Gu X, Veillon D, Cotelingam J.
    J La State Med Soc; 2016 Nov; 168(1):12-5. PubMed ID: 26986861
    [Abstract] [Full Text] [Related]

  • 12. Atypical hemolytic uremic syndrome: a new drug program and first Polish adult patient treated with eculizumab.
    Ruszkowski J, Heleniak Z, Dębska-Ślizień A.
    Pol Merkur Lekarski; 2018 Sep 21; 45(267):119-121. PubMed ID: 30240381
    [Abstract] [Full Text] [Related]

  • 13. A case of renal recovery in atypical hemolytic uremic syndrome treated with eculizumab.
    Farias JS, Cunha JP, Lagana CC, Gallucci MC, Chula DC, Soares MF, Nascimento MM.
    J Bras Nefrol; 2016 Mar 21; 38(1):137-41. PubMed ID: 27049376
    [Abstract] [Full Text] [Related]

  • 14. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
    Vondrák K, Seeman T.
    Transplant Proc; 2018 Apr 21; 50(3):967-970. PubMed ID: 29661469
    [Abstract] [Full Text] [Related]

  • 15. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Kato H, Miyakawa Y, Hidaka Y, Inoue N, Ito S, Kagami S, Kaname S, Matsumoto M, Mizuno M, Matsuda T, Shimono A, Maruyama S, Fujimura Y, Nangaku M, Okada H.
    Clin Exp Nephrol; 2019 Jan 21; 23(1):65-75. PubMed ID: 29959568
    [Abstract] [Full Text] [Related]

  • 16. Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumab.
    Green H, Harari E, Davidovits M, Blickstein D, Grossman A, Gafter U, Gafter-Gvili A.
    Ren Fail; 2014 Aug 21; 36(7):1119-21. PubMed ID: 24828571
    [Abstract] [Full Text] [Related]

  • 17. Autoimmune-type atypical hemolytic uremic syndrome treated with eculizumab as first-line therapy.
    Hisano M, Ashida A, Nakano E, Suehiro M, Yoshida Y, Matsumoto M, Miyata T, Fujimura Y, Hattori M.
    Pediatr Int; 2015 Apr 21; 57(2):313-7. PubMed ID: 25868950
    [Abstract] [Full Text] [Related]

  • 18. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.
    Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, Menne J, Minetti EE, Provôt F, Rondeau E, Ruggenenti P, Weekers LE, Ogawa M, Bedrosian CL, Legendre CM.
    Am J Kidney Dis; 2016 Jul 21; 68(1):84-93. PubMed ID: 27012908
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey.
    Gediz F, Payzin BK, Ecemis S, Güler N, Yilmaz AF, Topcugil F, Berdeli A.
    Transfus Apher Sci; 2016 Dec 21; 55(3):357-362. PubMed ID: 27742267
    [Abstract] [Full Text] [Related]

  • 20. Relapse of Atypical Hemolytic Uremic Syndrome During Pregnancy in a Patient on Eculizumab Maintenance Treatment: A Case Report.
    Fontana F, Alfano G, Bardhushi E, Ligabue G, Giovanella S, Neri I, Cappelli G.
    Am J Case Rep; 2019 Oct 04; 20():1460-1465. PubMed ID: 31582717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.